Contributing Factors on Pharmacokinetic Variability in Critically Ill Neonates.
10.24304/kjcp.2017.27.2.63
- Author:
Sook Hee AN
1
Author Information
1. College of Pharmacy, Wonkwang University, Jeonbuk 54538, Republic of Korea. shan7@wku.ac.kr
- Publication Type:Review
- Keywords:
Neonates;
neonatal intensive care unit;
pharmacokinetics;
preterm infants
- MeSH:
Amikacin;
Asphyxia;
Birth Weight;
Body Weight;
Comorbidity;
Critical Illness*;
Drug Therapy;
Ductus Arteriosus, Patent;
Gestational Age;
Humans;
Hypothermia, Induced;
Hypoxia-Ischemia, Brain;
Ibuprofen;
Indomethacin;
Infant, Newborn*;
Infant, Premature;
Intensive Care, Neonatal;
Membranes;
Oxygen;
Pharmacokinetics;
Vancomycin
- From:Korean Journal of Clinical Pharmacy
2017;27(2):63-68
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Neonates have large inter-individual variability in pharmacokinetic parameters of many drugs due to developmental differences. The aim of this study was to investigate the factors affecting the pharmacokinetic parameters of drugs, which are commonly used in critically ill neonates. Factors that reflect physiologic maturation such as gestational age, postnatal age, postconceptional age, birth weight, and current body weight were correlated with pharmacokinetic parameters in neonates, especially preterm infants. Comorbidity characteristics affecting pharmacokinetics in critically ill neonates were perinatal asphyxia, hypoxic ischemic encephalopathy, patent ductus arteriosus (PDA), and renal dysfunction. Administration of indomethacin or ibuprofen in neonates with PDA was associated with the reduced clearance of renally excreted drugs such as vancomycin and amikacin. Therapeutic hypothermia and extracoporeal membrane oxygenation were influencing factors on pharmacokinetic parameters in critically ill neonates. Dosing adjustment and careful monitoring according to the factors affecting pharmacokinetic variability is required for safe and effective pharmacotherapy in neonatal intensive care unit.
